Maternal pseudo primary hyperaldosteronism in twin-to-twin transfusion syndrome
Article first published online: 6 DEC 2006
DOI: 10.1111/j.1471-0528.2006.01152.x
RCOG 2007 BJOG An International Journal of Obstetrics and Gynaecology
Issue

BJOG: An International Journal of Obstetrics & Gynaecology
Volume 114, Issue 1, pages 65–69, January 2007
Additional Information
How to Cite
Gussi, I., Nizard, J., Yamamoto, M., Robyr, R. and Ville, Y. (2007), Maternal pseudo primary hyperaldosteronism in twin-to-twin transfusion syndrome. BJOG: An International Journal of Obstetrics & Gynaecology, 114: 65–69. doi: 10.1111/j.1471-0528.2006.01152.x
Publication History
- Issue published online: 6 DEC 2006
- Article first published online: 6 DEC 2006
- Accepted 2 October 2006.
- Abstract
- Article
- References
- Cited By
Keywords:
- Aldosterone;
- amnioreduction;
- haemodilution;
- laser therapy;
- plasma volume expansion;
- twin-to-twin transfusion syndrome
Objective To monitor changes in the maternal renin–angiotensin–aldosterone system following laser therapy and amnioreduction in severe twin-to-twin transfusion syndrome (TTTS).
Design Observational prospective study.
Setting Single university hospital in Poissy, France.
Population Sixty cases of TTTS at 16–26 weeks of gestation.
Method Maternal blood sampling before, 6 and 24 hours following the procedure.
Main outcome measures Plasma levels of aldosterone, renin, angiotensin II (AII), atrial natriuretic peptide (ANP), vasopressin, sodium, potassium and plasma proteins together with full blood count were measured before, 6 and 24 hours following the procedure.
Results TTTS is associated with maternal hyperaldosteronism dissociated from renin–angiotensin changes. Correcting TTTS by placental surgery and amnioreduction triggers incomplete correction of hyperaldosteronism, as early as 6 hours following the procedure, without changes in AII but an increase in the levels of ANP in plasma. Electrolyte concentrations remained stable despite haemodilution, while vasoactive hormone levels such as that of vasopressin remained unchanged.
Conclusion Mechanisms involved in marked fluid retention in TTTS are rapidly corrected by laser therapy followed by amnioreduction while maintaining electrolyte homeostasis.

1471-0528/asset/BJO_left.gif?v=1&s=0fb87361cdb6be25fdf05019eed6d47f5143f610)
1471-0528/asset/olbannerright.gif?v=1&s=3892ef16ff18d6834c302faf85268a49f5fc588f)